Lexeo Therapeutics, Inc.
Lexeo Therapeutics, Inc. (LXEO) — Form 144: Proposed sale of shares
About this filing
Lexeo Therapeutics, Inc. (LXEO) filed Form 144 (proposed sale of shares) with the SEC on Nov 17, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.
Key facts
- Seller
- Otero Jose Manuel
- Relationship
- Officer
- Shares to sell
- 1,285
- Market value
- $4,192.19
- Approximate sale date
- Nov 17, 2026
- Broker
- Fidelity Brokerage Services LLC
- Acquired
- Nov 16, 2026 · Restricted Stock Vesting
Remarks
- Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
More LXEO filings
- 4
Filed Nov 17, 2026
- 3
Filed Nov 17, 2026
- 144
Filed Nov 17, 2026
- 144
Filed Nov 17, 2026
- SC 13G/A
Filed Nov 16, 2026
- SC 13G/A
Filed Nov 16, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.